CA2696400A1 - Composition d'agent hemostatique et procede d'administration - Google Patents

Composition d'agent hemostatique et procede d'administration Download PDF

Info

Publication number
CA2696400A1
CA2696400A1 CA2696400A CA2696400A CA2696400A1 CA 2696400 A1 CA2696400 A1 CA 2696400A1 CA 2696400 A CA2696400 A CA 2696400A CA 2696400 A CA2696400 A CA 2696400A CA 2696400 A1 CA2696400 A1 CA 2696400A1
Authority
CA
Canada
Prior art keywords
composition
wound
hemostatic agent
site
hemostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2696400A
Other languages
English (en)
Inventor
Jack Mentkow
Lisa Mentkow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/191,323 external-priority patent/US8409629B2/en
Application filed by Individual filed Critical Individual
Publication of CA2696400A1 publication Critical patent/CA2696400A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition d'agent hémostatique qui comprend un agent hémostatique à base d'argile qui est inerte et non réactif par rapport aux protéines de la coagulation sanguine et aux plaquettes, et qui est pourtant capable d'accélérer la formation d'un caillot stable lorsqu'il est appliqué sur une plaie saignant activement.
CA2696400A 2007-08-16 2008-08-18 Composition d'agent hemostatique et procede d'administration Abandoned CA2696400A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US96495507P 2007-08-16 2007-08-16
US60/964,955 2007-08-16
US12/191,323 US8409629B2 (en) 2006-01-09 2008-08-14 Hemostatic agent composition and method of delivery
US12/191,323 2008-08-14
PCT/US2008/009830 WO2009025782A2 (fr) 2007-08-16 2008-08-18 Composition d'agent hémostatique et procédé d'administration

Publications (1)

Publication Number Publication Date
CA2696400A1 true CA2696400A1 (fr) 2009-02-16

Family

ID=40378868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2696400A Abandoned CA2696400A1 (fr) 2007-08-16 2008-08-18 Composition d'agent hemostatique et procede d'administration

Country Status (10)

Country Link
EP (1) EP2197422A2 (fr)
JP (1) JP2010536762A (fr)
CN (1) CN101778623A (fr)
AU (1) AU2008289571A1 (fr)
BR (1) BRPI0817049A2 (fr)
CA (1) CA2696400A1 (fr)
MX (1) MX2010001820A (fr)
RU (1) RU2010109699A (fr)
WO (1) WO2009025782A2 (fr)
ZA (1) ZA201001845B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL254644B (en) * 2017-09-24 2021-06-30 Reddress Ltd Device for dressing a wound, system and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7139653B2 (en) * 2004-07-15 2006-11-21 International Truck Intellectual Property Company, Llc Common control interface for diverse automated manual transmissions
CN101160143A (zh) * 2005-02-15 2008-04-09 弗吉尼亚大学 用于急性止血、治疗急性损伤和慢性溃疡的矿物技术（mt）
US9474652B2 (en) * 2006-01-09 2016-10-25 Jack Mentkow Hemostatic agent delivery system

Also Published As

Publication number Publication date
AU2008289571A1 (en) 2009-02-26
RU2010109699A (ru) 2011-09-27
WO2009025782A3 (fr) 2009-04-09
MX2010001820A (es) 2010-06-02
CN101778623A (zh) 2010-07-14
JP2010536762A (ja) 2010-12-02
BRPI0817049A2 (pt) 2015-03-24
WO2009025782A2 (fr) 2009-02-26
ZA201001845B (en) 2011-02-23
EP2197422A2 (fr) 2010-06-23

Similar Documents

Publication Publication Date Title
US8409629B2 (en) Hemostatic agent composition and method of delivery
US8609129B2 (en) Hemostatic agent composition, delivery system and method
US9474652B2 (en) Hemostatic agent delivery system
US7303759B2 (en) Compositions and methods for reducing blood and fluid loss from open wounds
EP2427157B1 (fr) Dispositifs et méthodes de lutte contre l'hémorragie
US10973946B1 (en) Haemostatic material
CN106456569B (zh) 用于递送护肤组合物的装置
US9950091B2 (en) Composition and method for stopping hemorrhage, infection, and accelerating healing in various types of wound or burns
Clay et al. Comparative testing of new hemostatic agents in a swine model of extremity arterial and venous hemorrhage
JP2005503197A (ja) 創傷被覆材、および重篤で生命にかかわる出血を制御する方法
CN101081308A (zh) 壳聚糖止血剂
JP6554474B2 (ja) ラップを含む外傷性創傷ドレッシングシステム
CN109689069A (zh) 具有止血作用的伤口覆盖物及其产生方法
US20130022552A1 (en) Blood clotting composition and method of use
WO2004108035A1 (fr) Pansements bases sur le gradient de teorell-meyer
CA2696400A1 (fr) Composition d'agent hemostatique et procede d'administration
Burgert et al. Effects of arterial blood pressure on rebleeding using Celox and TraumaDEX in a porcine model of lethal femoral injury
RU2810584C1 (ru) Термоуправляемая композиция для временной остановки кровотечений
Ryan et al. Overview of the hemostasis research program: advances and future directions
Xie et al. Comparison of Hemostatic Efficacy of ChitoGauze and Combat Gauze in a Lethal Femoral Arterial Injury in Swine Model
CN114269350A (zh) 局部止血组合物
Champagne Serendipity, Super Glue and Surgery: Cyanoacrylates as Hemostatic Aids in the Vietnam War
Allison et al. Battlefield-Tested Hemostatic Agents: Their Applications for Hemorrhage Control in Hospital Settings Battlefield-Tested Hemostatic Agents: Their Applications for Hemorrhage Control in Hospital Settings
AU2015202402A1 (en) Haemostatic material
EP1608301A1 (fr) Pansements bases sur le gradient de teorell-meyer

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130820

FZDE Discontinued

Effective date: 20130820